FDA approves automated hepatitis B test

Jul 19, 2006

The U.S. Food and Drug Administration has approved the first automated product combining screening and confirmatory tests for hepatitis B surface antigen.

The Illinois-headquartered Abbott Laboratories' PRISM HBsAg assay was approved to test people who donate blood, blood components, and organs for the hepatitis B virus. The test also may be used to screen blood from cadavers for organ and tissue donation.

The FDA said the assay also was approved for the confirmation of samples it found to be reactive. Currently, screening and confirmatory tests are performed separately.

"This automated test system increases the efficiency and convenience of screening blood, tissue and organ donors for the hepatitis B virus," said Dr. Jesse Goodman, director of the FDA's Center for Biologics Evaluation and Research. "Improvements in blood donor screening and testing over the last few years have helped make the nation's blood supply safer from infectious diseases than it has been at any other time."

Hepatitis B, caused by a virus that infects the liver, can only be determined by a blood test.

Copyright 2006 by United Press International

Explore further: Senegal monitors contacts of 1st Ebola patient

add to favorites email to friend print save as pdf

Related Stories

Carlyle Group makes $4.15B offer for J&J business

Jan 16, 2014

Johnson & Johnson said Thursday that it's been offered $4.15 billion by The Carlyle Group for its Ortho-Clinical Diagnostics business, a year after J&J began reviewing strategic options for the blood-testing ...

Most detailed picture ever of key part of hepatitis C

Nov 28, 2013

Scientists at The Scripps Research Institute (TSRI) have determined the most detailed picture yet of a crucial part of the hepatitis C virus, which the virus uses to infect liver cells. The new data reveal ...

Target 'super-spreaders' to stop hepatitis C

Jan 31, 2013

Each intravenous drug user contracting Hepatitis C is likely to infect around 20 other people with the virus, half of these transmissions occurring in the first two years after the user is first infected, a new study estimates.

New vaccine technology protects mice from hepatitis C virus

Feb 23, 2011

Immunology: Three percent of the world's population is currently infected by hepatitis C. The virus hides in the liver and can cause cirrhosis and liver cancer, and it's the most frequent cause of liver transplants in Denmark. ...

Recommended for you

Senegal monitors contacts of 1st Ebola patient

1 hour ago

Senegalese authorities on Monday were monitoring everyone who was in contact with a student infected with Ebola who crossed into the country, and who has lost three family members to the disease.

Family dinners reduce effects of cyberbullying in adolescents

1 hour ago

Sharing regular family meals with children may help protect them from the effects of cyberbullying, according to a study by McGill professor Frank Elgar, Institute for Health and Social Policy. Because family meal times represent ...

Location of body fat can increase hypertension risk

1 hour ago

People with fat around their abdominal area are at greater risk of developing hypertension when compared to those with similar body mass index but fat concentrations elsewhere on the body, according to a ...

User comments : 0